United Therapeutics (UTHR) Minority Interest (2009 - 2016)

United Therapeutics has disclosed Minority Interest across 8 years of filings, most recently posting $10.9 million for Q4 2016.

• Minority Interest for Q4 2016 came in at $10.9 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2016 was $10.9 million (changed 0.0% YoY), and the FY2016 annual result was $10.9 million, changed 0.0% from the prior year.
• Minority Interest came in at $10.9 million for Q4 2016 at United Therapeutics, roughly flat from $10.9 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $10.9 million in Q4 2015 to a low of $10.9 million in Q1 2012.
• The 5-year median for Minority Interest is $10.9 million (2012), against an average of $10.9 million.
• Across the five-year window, Minority Interest changed 0.0% in 2012 and increased 0.17% in 2015, its largest moves.
• United Therapeutics' Minority Interest stood at $10.9 million in 2012, then changed by 0.0% to $10.9 million in 2013, then changed by 0.0% to $10.9 million in 2014, then increased by 0.17% to $10.9 million in 2015, then changed by 0.0% to $10.9 million in 2016.
• The last three Minority Interest figures came in at $10.9 million (Q4 2016), $10.9 million (Q4 2015), and $10.9 million (Q3 2015), per Business Quant data.